Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )

Clinical trial NCT07340723 · RECRUITING

Trial details

NCT number: NCT07340723
Sponsor: Daihong Liu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

GVHD,Acute Stem Cell Transplant Complications

Start date: 2025-06-01
Primary completion: 2027-06-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.